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Results. It was determined that these cells are sensitive to radiation damage in a dose dependent manner and in an order of
magnitude that respects the theoretical prediction of biological efﬁcacy against both types of radiation employed.
Conclusion. This study establishes and characterizes the basics of a model of the original irradiation on a cell type not extensively
studied in terms of their response to radiation or clinical signiﬁcance in the toxicity and radiation repair: human mesenchymal
stemcells. Themodel developedanddescribed is the basis for increasing knowledgeof radiobiology of stemcells, and is applicable
to other cell types.
http://dx.doi.org/10.1016/j.rpor.2013.03.637
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Introduction. Ibandronate (IBD) is a bisphosphonate used in hypercalcaemia-related cancers, in complications from bone metas-
tasis and in postmenopausal osteoporosis and has often been associated with osteoradionecrosis, especially amongst cancer
patients receiving radiation to the head and neck area.
Objectives. To determine the cytotoxicity of IBD in combination with ionizing radiation (IR) treatment by evaluating its genotoxic
and cytotoxic effects in non-tumoral cells.
Methods. The genotoxic effect of IBD was studied by means of the micronucleus test in cytokinesis-blocked cells of human
lymphocytes irradiated to 2Gy irradiation, while the cytotoxic effect was studied by a cell viability test (MTT) in PNT2 cells before
and after exposure to different X-ray doses (0–20Gy). The results of these treatments were compared with those elicited by
recommended human dose of Zoledronic acid (Z5%).
Results. At the concentrations of IBD recommended for humans, we did not determine any genotoxic, cytotoxic or synergistic
effect with ionizing radiation. With higher concentrations we established a cytotoxic effect on PNT2 cells (p<0.001); the combined
treatment with IR had a more pronounced effect than individual treatments (p<0.001), increasing the enhancement ratio (1.3)
and sensitization factor (23.6%). With the concentration of Z(5%), the combined treatment had a more pronounced effect than
individual treatments(p<0.001). The effect was synergic (CI < 1), increasing the Z enhancement ratio (2.6) and sensitization factor
(56%). For the genotoxic effect, only the administration of Z after irradiation (IR+Z) increased chromosome damage (p<0.001)
and the sensitization factor (35.7%).
Conclusion. The recommended clinical concentrations of IBD did not induce cytotoxic or genotoxic damage in non-tumor cells
neither did it show an additive effect with the IR. Only at very high concentrations is an increase in cytotoxicity with signiﬁcant
radiosensitizing noted similar to that produced by Z5%.
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Purpose. To determine the potentially paradoxical effect of rosmarinic acid (RA), typically being radioprotective when applied to
non-tumour cells yet conversely displaying a sensitizing action when applied to metastatic (B16F10) melanoma cells.
Methods. To analyze the radioprotective effects of the substances studied on cell viability and survival, we used the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay for 24 or 48h in B16F10 (melanoma) cell lines when they
were administered before exposure to different X-ray doses (4, 6, 8, 10 and 0Gy). An analysis of variance (ANOVA) of repeated
means was used to compare the percentages of surviving cells. This was complemented by least signiﬁcant deference analyses
to contrast pairs and means. To determine the Protection Factor (PF) the formula described by Sarma and Kesavan (1993) was
modiﬁed for the analysis of growth inhibition.
Results. RA shows a signiﬁcant genoprotective capacity (p<0.001) against X-rays with a protection factor of 58%, and a dose
reduction factor of 7.2. Cell survival obtained with RA after exposure to 10Gy of X-rays showed a protection factor of 47.5%, thus
eliminating 29.1% of radiation-induced cell death in normal prostate epithelial cells (PNT2) (p<0.001). However, in the metastatic
B16F10 melanoma cells, RA acted not as a radioprotector but as a sensitizing agent, increasing cellular death by 42% (p<0.001)
and producing an enhancement ratio of 2.36.
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Conclusions. RA shows an increased capacity for producing radioinduced damage, and thus a paradoxical damaging effect, in
melanoma cells. Potentially, research into substances like RA could help to clarify mechanisms that may provide protection to
healthy normal cells while exclusively damaging neoplastic cell, thus presenting a new strategy for cancer patients undergoing
radiotherapy.
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Introduction. Breast cancer is a leading death cause among 30 and 50 years old women from industrialized countries and distal
metastases after treatment are the main responsible of this high death rate. Ionizing radiation (IR) along with chemotherapy
has traditionally been used as ﬁrst-line therapy against breast cancer. Protocol optimization led us to improve clinical breast
cancer outcome. However, during the last decade, some epidemiological and translational studies have been pointing out some
tumour-promoting properties in those cells that survive after radiation exposure. Matrix metalloproteinases (MMPs) have been
proposed as one of the main candidates to enrol this effect since MMPs have been described as chief proteases involved in stromal
ﬁbre turnover.
Hypothesis. The purpose of this study was to evaluate in vitro the MMP contribution to second malignancies arising after breast
radiotherapy (RT) and to demonstrate whether this effect might be epigenetically softened.
Materials and methods. Two breast cancer cell lines MDA-MB-231 and MCF-7 were cultured in DMEM supplemented with 10%
FBS. Radiation-derived MMP levels were measured by both real-time PCR and WesternBlot. Gelatinolytic activity was detected by
confocal microscopy and an ELISA-like assay using DQ gelatin. Invasion capability after radiation was also quantiﬁed.
Results. Our results revealed that MDA-MB-231 signiﬁcantly enhanced invasion capability after IR exposure. Gene and protein
expression analyses revealed increased amounts of MMP-1 (collagenase), MMP-3 (stromelysin) and both TIMP-1 and TIMP-2
(tissue inhibitors/activators of MMPs) after irradiation. MMP activity (measured by the amount of cleavage gelatine) was also
increased in this breast cancer cell line. In order to soften this radiation-induced MMP activity, the histone deacethylator inhibitor
valproic acid (VA) was tested. Our ﬁndings reﬂect that VA reduces both IR-enhanced MMP gene expression and activity. Moreover,
our data conﬁrm a dose-dependent radiosensitizing effect of VA.
Conclusions. Taken together, our results suggest that VA might be considered a potential adjuvant enhancer of breast radiotherapy
effectiveness. Our data reveal that VA not only is able to radiosensitize breast tumour cells but also to reduce RT-derived tumour-
promoting effects.
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Stem-like cells from breast cancer: Crucial players in celullar response to radiotherapy
E. RománMarinetto1, G. Jiménez2, S. RíosArrabal1, F. ArtachoCordón1, J. Expósito3, E. LópezRuiz2, A. Ramírez2,
J. León4, J. Marchal2, M. Nún˜ez Torres1
1 Universidad de Granada, Radiología y Medicina Física, Spain
2 Universidad de Granada, Anatomía y Embriología Humana, Spain
3 Hospital Universitario Virgen De Las Nieves, Complejo Hosp., Servicio de Oncología Radioterápica, Spain
4 Hospital Clínico Universitario San Cecilio, Área de Apoyo a la Investigación, Spain
Introduction. Although radiotherapy approach has improved local control and survival rates with acceptable toxicity, recurrence
is essentially seen in most patients and some of them develop radioresistance that might limit any further treatment. Stem-
like cells (SLCs) isolation from breast tumors has allowed the analysis of the molecular mechanism involved in their origin,
self-renewal, differentiation into tumor cells, resistance to radio and chemotherapy, and invasiveness and metastatic ability.
Hypothesis. The purpose of this work was to evaluate the role of SLCs in breast cancer response to radiotherapy. We have studied
the inﬂuence of ionizing radiation (IR) exposure in tumor SLCs enrichment and whether this subpopulation contributes to tumor
radioresistance. Evaluation of IR-induced tumor-promoting properties in those SLCs has also been carried out.
Materials and methods. Two breast cancer cell lines (MCF-7 and MDA-MB-231) and SLCs, sorted by ﬂow cytometry from those cell
cultures, were grown at 37 ◦C and 5% CO2 in DMEM supplemented with 10% FBS and stem cell culture medium, respectively. Cells
were irradiated 24h after seeding and harvested 24h later. Radiation-induced invasiveness-related matrix metalloproteinases
